SCHEMBL9153738

SCHEMBL9153738

Cn1c(=O)[nH]c(=O)c2nc(-c3ccc(C=CC(=O)O)cc3)[nH]c21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 10/20 0.54
▸ ADORA3 P0DMS8 6/20 0.54
▸ ADORA2A P29274 6/20 0.53
▸ ADORA1 P30542 4/20 0.53
▸ PTPN1 P18031 1/20 0.46
▸ KMT2A Q03164 3/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ GAA P10253 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ CA12 O43570 1/20 0.36
▸ AKR1B10 O60218 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ ESR1 P03372 1/20 0.36
▸ CA3 P07451 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ TYR P14679 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9153726 1.00 ADORA2B (0.54) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL9155055 0.88 ADORA2B (0.66) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL9155062 0.88 ADORA2B (0.66) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL9151995 0.88 ADORA2B (0.57) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL9151989 0.88 ADORA2B (0.57) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL9156870 0.85 ADORA2B (0.52) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL9156883 0.85 ADORA2B (0.52) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL6554063 0.84 ADORA2B (0.55) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL6554060 0.84 ADORA2B (0.55) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL9158568 0.83 ADORA2B (0.52) ADORA2BADORA3ADORA2AADORA1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0639055-A1 METHODS OF TREATING OBESITY WITH PURINE RELATED COMPOUNDS THE PENN STATE RESEARCH FOUNDATION (US) 1995-02-22 — — EP claimed
WO-1993021783-A1 METHODS OF TREATING OBESITY WITH PURINE RELATED COMPOUNDS THE PENN STATE RESEARCH FOUNDATION (US) 1993-11-11 — — WO claimed
EP-0203721-B1 8-PHENYL XANTHINES THE WELLCOME FOUNDATION LIMITED (GB) 1992-06-10 — — EP claimed
US-4879296-A BLOCKING ADERNOSINE CELL SURFACE EFFECTS BURROUGHS WELLCOME CO. (US) 1989-11-07 — — US claimed
EP-0203721-A2 8-Phenyl xanthines THE WELLCOME FOUNDATION LIMITED (GB) 1986-12-03 — — EP claimed
EP-0639055-A1 METHODS OF TREATING OBESITY WITH PURINE RELATED COMPOUNDS THE PENN STATE RESEARCH FOUNDATION (US) 1995-02-22 — — EP disclosed
US-5300298-A Methods of treating obesity with purine related compounds THE PENNSYLVANIA RESEARCH CORPORATION (US) 1994-04-05 — — US disclosed
WO-1993021783-A1 METHODS OF TREATING OBESITY WITH PURINE RELATED COMPOUNDS THE PENN STATE RESEARCH FOUNDATION (US) 1993-11-11 — — WO disclosed
EP-0243192-B1 ANTIVIRAL 8-PHENYLXANTHINES THE WELLCOME FOUNDATION LIMITED (GB) 1992-07-15 — — EP disclosed
EP-0203721-B1 8-PHENYL XANTHINES THE WELLCOME FOUNDATION LIMITED (GB) 1992-06-10 — — EP disclosed
US-5017577-A Using Purine Cinnamic Acids BURROUGHS WELLCOME CO. (US) 1991-05-21 — — US disclosed
US-5015647-A Using Purine Cinnamic Acid Compounds BURROUGHS WELLCOME CO. (US) 1991-05-14 — — US disclosed
US-4981857-A ADENOSINE ANTAGONIST BURROUGHS WELLCOME CO. (US) 1991-01-01 — — US disclosed
US-4879296-A BLOCKING ADERNOSINE CELL SURFACE EFFECTS BURROUGHS WELLCOME CO. (US) 1989-11-07 — — US disclosed
EP-0243192-A2 Antiviral 8-Phenylxanthines THE WELLCOME FOUNDATION LIMITED (GB) 1987-10-28 — — EP disclosed
EP-0203721-A2 8-Phenyl xanthines THE WELLCOME FOUNDATION LIMITED (GB) 1986-12-03 — — EP disclosed
Send feedback